Key participants include co-chairs from the FTC's Bureaus of Competition and Consumer Protection, with members from the Bureaus of Economics, Office of Policy Planning, Office of Technology, and Office of General Counsel; the task force will expand to partners like the Department of Health and Human Services and Department of Justice[1][4][9]. It will lead targeted initiatives, devise investigation strategies, file amicus briefs, and conduct "horizon-scanning" for emerging issues like AI, telehealth, and data platforms, meeting monthly and reporting quarterly to Ferguson[4][6][7][15].
This follows President Trump's February 25, 2025 Executive Order directing agencies to foster a more competitive, innovative, affordable healthcare system via price transparency and enforcement, building on bipartisan FTC trends in healthcare scrutiny[1][3][4][8]. Recent FTC actions targeted pharmacy benefit managers, medical devices, and misleading ads[1].
Newsworthy as it signals intensified regulatory scrutiny under the second Trump administration—two weeks before the headline date—formalizing cross-bureau coordination amid rising healthcare costs and consolidation, positioning FTC as a key policy shaper without new rulemaking authority[2][6][8][12].